Sellke F W, Stanford W, Rossi N P
Department of Surgery, University of Iowa, College of Medicine, Iowa City 52242.
J Cardiovasc Surg (Torino). 1991 Nov-Dec;32(6):820-3.
Internal mammary arteries and saphenous vein grafts are the most satisfactory conduits for coronary artery bypass. However, at times these conduits are not available, due to previous use or poor quality. This paper reports our experience with 6 patients who underwent coronary artery bypass operations using 10 cryopreserved saphenous veins and internal mammary arteries. Postoperative graft patency was assessed with ultra fast computed tomography or cardiac catheterization. At operation, venous graft patency was 100% (10/10), at 1-8 weeks was 60% (6/10), and at 6-30 months was 0% (0/9). Alternately, all seven internal mammary artery grafts were patent at 2 to 18 months following surgery. One patient died 6 months following operation. Poor graft patency may be related to destruction of the cellular components or fibrosis resulting from the cryopreservation process or from immunologic factors. Because of poor patency compared to autologous conduits, we conclude the use of cryopreserved saphenous veins for coronary artery bypass should be severely restricted.
乳内动脉和大隐静脉移植物是冠状动脉搭桥最理想的血管 conduit 。然而,有时由于先前已使用或质量不佳,这些 conduit 无法获得。本文报告了我们对 6 例患者的经验,这些患者使用 10 条冷冻保存的大隐静脉和乳内动脉进行了冠状动脉搭桥手术。术后通过超快速计算机断层扫描或心导管检查评估移植物通畅情况。手术时,静脉移植物通畅率为 100%(10/10),1 - 8 周时为 60%(6/10),6 - 30 个月时为 0%(0/9)。相比之下,所有七条乳内动脉移植物在术后 2 至 18 个月均保持通畅。一名患者术后 6 个月死亡。移植物通畅性差可能与冷冻保存过程或免疫因素导致的细胞成分破坏或纤维化有关。由于与自体 conduit 相比通畅性较差,我们得出结论,冷冻保存的大隐静脉用于冠状动脉搭桥应受到严格限制。 (注:文中“conduit”根据语境推测可能是“血管导管”之类的意思,但不确定准确医学术语,暂保留英文)